Why is NTLA Up Today?
About Intellia Therapeutics, Inc
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering speci...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
NORMAL - This move is backed by significant volume and appears sustainable.
📍 Sector Context
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector: -1.8%
Market Comparison
🔔 Get NTLA Alerts
We'll notify you when NTLA's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
NTLA has moved more than 3.0% up on 58 occasions in the past year.
Frequently Asked Questions
Why is NTLA stock up today?
This stock is significantly outperforming its IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector peers, suggesting a stock-specific catalyst.
Is NTLA stock a buy or sell right now?
Based on current analysis, NTLA shows 65% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →
What is the NTLA stock price target?
NTLA is currently trading at $12.42. Based on today's momentum, the expected short-term range is $12.17 - $12.79. See long-term price prediction →
Will NTLA stock continue rising?
Our analysis shows a 45% probability that NTLA's move continues in the next 1-3 days. Key level to watch: $13.04 (resistance).
Is NTLA stock oversold or overbought?
NTLA's RSI (Relative Strength Index) is currently at 51.2. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for NTLA stock?
NTLA's 10-day momentum indicator is at 0.02. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is NTLA outperforming or underperforming the market?
NTLA (+2.94%) is currently significantly outperforming the market (+2.8% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for NTLA?
NTLA's MACD (-0.13) is currently above the signal line (-0.16), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 13.4) is weak.
Is NTLA in an uptrend or downtrend?
Based on moving average analysis, NTLA is in a bullish trend. The price ($12.42) is trading above both the 20-day SMA ($12.11) and 50-day SMA ($12.0). This alignment typically indicates sustained upward momentum.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis